Work

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically

Year: 1998

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s002800050852

Authors: Primo N. Lara Jr., David R. Gandara, Gregory T. Wurz, Derick Lau, Margaret Uhrich, Corinne Turrell, James Raschko, Martin J. Edelman, Timothy Synold, James Doroshow, Franco Muggia, Edith A. Perez, Mike DeGregorio

Institutions: UC Davis Comprehensive Cancer Center, University of California, Davis, City Of Hope National Medical Center, VA Northern California Health Care System, USC Norris Comprehensive Cancer Center, Mayo Clinic, Mayo Clinic in Florida

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1194427597, G2701235145, Phase I Molecular and Clincal Pharmacodynamic Trials, PHARMACODYNAMIC PHASE II BREAST, LUNG AND OVARY TRIALS

OpenAlex ID: W2002258376

FWCI:

Cites: 11

Cited by: 11

Related to: 10